Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-080871

CRESCENT BIOPHARMA, INC. · CBIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 2:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 16, 2015X9,445$0.33A4,491,203ISee Note 1
Common StockF1Nov 16, 2015S452$6.91D4,490,751ISee Note 1
Common StockF3holding———4,093,377ISee Note 3

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant to Purchase Common Stock (right to buy)F1$0.33Nov 16, 2015X9,445DDec 9, 2005Dec 9, 2015Common Stock9,4450I

Explanation of responses